$4.25
-0.10 (-2.30%)
Open$4.22
Previous Close$4.35
Day High$4.51
Day Low$4.21
52W High$94.50
52W Low$3.60
Volume—
Avg Volume464.0K
Market Cap2.64M
P/E Ratio—
EPS$-1.51
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.79M | 1.37M | 1.35M |
| Net Income | -13,432,845 | 393.8K | 424.2K |
| Profit Margin | -480.9% | 28.8% | 31.3% |
| EBITDA | -14,630,677 | 809.4K | 830.6K |
| Free Cash Flow | — | 304.8K | 355.4K |
| Rev Growth | — | -0.9% | -3.8% |
| Debt/Equity | 0.01 | 0.83 | 1.09 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |